glucose 5% freeflex glucose 12.5 g/250 ml injection bag
fresenius kabi australia pty ltd - glucose, quantity: 12.5 g - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.
glucose 5% freeflex glucose 2.5g/50ml injection bag
fresenius kabi australia pty ltd - glucose, quantity: 2.5 g - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.
glucose 5% freeflex glucose 5g/100ml injection bag
fresenius kabi australia pty ltd - glucose, quantity: 5 g - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.
glucose injection (baxter)
baxter healthcare ltd - glucose monohydrate 50% - solution for infusion - 50 % - active: glucose monohydrate 50% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.
glucose 50%
aft pharmaceuticals ltd - glucose monohydrate 50% - solution for infusion - 50 % - active: glucose monohydrate 50% excipient: water for injection
glucose 5 % intravenous infusion bp
teva medical marketing ltd. - glucose monohydrate - solution for infusion - glucose monohydrate 5.5 %w/v - glucose - glucose - glucose 5 % intravenous infusion is indicated for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.
glucose 5 % intravenous infusion bp
teva medical marketing ltd. - glucose monohydrate - solution for infusion - glucose monohydrate 5.5 %w/v - glucose - glucose - glucose 5 % intravenous infusion is indicated for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.
glucose- dextrose monohydrate injection
baxter healthcare corporation - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose monohydrate 2.5 g in 50 ml
glucose 5 % intravenous infusion bp
teva medical marketing ltd. - glucose monohydrate - solution for infusion - glucose monohydrate 5.5 %w/v - glucose - glucose - for the treatment of carbohydrate and fluid depletion. glucose 5 % is also used as a vehicle and diluent for compatible medicinal products for parenteral administration.
baxter 5% glucose intravenous infusion glucose 1000ml bag
baxter healthcare pty ltd - glucose, quantity: 45 g (equivalent: glucose monohydrate, qty 50 g) - injection - excipient ingredients: water for injections - glucose (5%) intravenous infusions are mainly indicated: - whenever non-electrolyte fluid replacement is required. - as a vehicle for drug delivery, provided that the added components are compatible with glucose.